Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07784608Phase 1Not yet recruiting
Phase 1, open-label, single-arm trial of atorvastatin and telmisartan in hypercholesterolemia and hypertension (HTN), sponsored by Huons. Primary endpoints: Area Under the Concentration-Time Curve Over the Dosing Interval at Day 22 and Maximum Steady-State Plasma Concentration at Day 22. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07784608.